At a Glance
- Company: Droplet Biosciences
- Location: Cambridge, Massachusetts
- Headline figures: Analysis from 10 days to <2 days; 30% cost reduction
- Focus area: Lymphatic fluid ctDNA for MRD in head/neck cancer
- Next steps: Full Parabricks integration; 1-day turnaround
What happened?
Droplet Biosciences announced a collaboration with Nvidia on 3 March 2026 to accelerate genomic analysis using NVIDIA Parabricks GPU software. The partnership slashes processing times for lymphatic fluid tests detecting residual cancer post-surgery, from 10 days to under two days.
Why does it matter?
Traditional blood ctDNA tests take 4-6 weeks for tumour markers to appear; lymphatic fluid from surgical drains offers 24-hour detection via high biomarker concentration. Speed enables immediate adjuvant decisions during hospital stays, validated CLIA for HPV-negative head/neck cancer.
Who’s behind it?
Droplet pioneers lymph-based liquid biopsy; Nvidia provides Parabricks acceleration. CSO Wendy Winckler and informatics head Zhuosheng Gu led implementation.
How was it achieved?
Parabricks reduced variant calling from 36 to <3 hours, alignment from 10 to <1 hour using L4/L40S GPUs. Despite higher hourly GPU costs, shorter runtimes cut total expense 30% per sample.
What’s next?
Optimise for 1-day results; expand to other cancers. Partners include Pitt, Cleveland Clinic, Mayo Clinic via early access.
What are people saying?
CSO Winckler: “Compress… steps from >1 day to few hours.” Nvidia’s Rory Kelleher: “Transforms… cancer detection.”